Mashkovskii, Drugs (Chloditan) [in Russian
- D. M
- Novaya Volna, Moscow
A new drug formulation of the adrenal cortex (AC) inhibitor o,p′-DDD (chloditan) was developed as a solution for i.v. injection. Its effects on glucocorticoid hormone production by human AC tissue culture and AC function in dogs were studied. A concentration range of 0.005 – 5.0 mg/mL was established by adding 5% o,p′-DDD solution to the culture medium. Cultivation of specimens of human adrenocortical tissue in the presence of o,p′-DDD solution caused after 24 h a dose-dependent decrease of 11-hydroxycorticosteroid (11-HCS) content by 11.0 – 69.8%. The 11-HCS content in dog blood plasma decreased by an average of 3.5 times; the response to synthetic 1 – 24-corticotropin stimulation, by three times, with daily administration for 3 d of 10 mL of the solution. The 11-HCS blood level was still reduced two weeks after withdrawal of the drug. The proposed o,p′-DDD solution showed adrenocorticolytic activity and could be recommended for clinical trials.